Viridian Therapeutics, Inc.\DE

VRDN

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-092028
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+95,800.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

95,800.0

Transaction 2

Security

Restricted Stock Units

Action

Grant

Date

2026-03-02

Code

A

Net shares

+19,150.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

19,150.0

Filing's footnotes

1. The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date. The date of the grant is March 2, 2026.

2. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.

3. The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.